AgWebUSDA Has No Plans To Regulate CRISPRAgWebUSDA on Wednesday gave the market a clear signal it will not seek to regulate emerging gene editing technologies that could open a new era of plant development for agriculture. U.S. Secretary of Agriculture… Continue reading
Earth.comStem cell injections have the potential to cure alcoholismEarth.comResearchers at the University of Chile have had a breakthrough that could ultimately lead to a cure for alcoholism. When the experts injected human stem cells into mice that ha… Continue reading
Biz Misled On Gene Therapy Toxicity Pre-IPO, Investors SayLaw360Biz Misled On Gene Therapy Toxicity Pre-IPO, Investors Say. By Cara Bayles. Law360 (March 28, 2018, 4:54 PM EDT) — Solid Biosciences Inc. has been accused of securities fraud in a Massach… Continue reading
Biz Misled On Gene Therapy Toxicity Pre-IPO, Investors SayLaw360Biz Misled On Gene Therapy Toxicity Pre-IPO, Investors Say. By Cara Bayles. Law360 (March 28, 2018, 4:54 PM EDT) — Solid Biosciences Inc. has been accused of securities fraud in a Massach… Continue reading
Epidermolysis Bullosa NewsKrystal Files Application to Start Clinical Trial of Gene Therapy Candidate KB103Epidermolysis Bullosa NewsKrystal Biotech has submitted an investigational new drug application with the U.S. Food and Drug Administration (FDA) … Continue reading
Brookings Institution (blog)Five ways to improve private investment in global health R&DBrookings Institution (blog)Anticipated advances in artificial intelligence and synthetic biology might accelerate scientific discovery and drug development. Id… Continue reading
OncLiveDr. Bellmunt on Immunotherapy Combination Trials in Bladder CancerOncLiveJoaquim Bellmunt, MD, PhD, associate professor of medicine, Harvard Medical School, director, Bladder Cancer Center, Dana-Farber Cancer Institute, discusses trials investig… Continue reading
Nasdaq FortuneEditas Medicine Names James C. Mullen as Chairman of the Board of DirectorsMarkets InsiderAs a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cpf1 genome edi… Continue reading